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Background: Childhood obesity is associated with an accelerated skeletal maturation. However
data concerning pubertal development and sex steroids levels in obese adolescents are scarce and
contrasting.
Objectives: To study sex steroids in relation to sexual and skeletal maturation and to serum PSA,
as a marker of androgen activity, in obese boys from early to late adolescence.
Methods: 90 obese boys (10–19 y) at the start of a residential obesity treatment program and 90
age-matched controlswere studied cross-sectionally. Pubertal statuswas assessed according to the
Tannermethod. Skeletal agewas determined by an X-ray of the left hand.Morning concentration
of total testosterone (TT) andestradiol (E2) by LC-MS/MS, free T (FT) by equilibriumdialysis, and LH,
FSH, SHBG and PSA by immunoassays, were measured.
Results: Genital staging was comparable between the obese and non-obese group, whereas skel-
etalboneadvancement (mean1year)waspresent inearlyandmid-adolescence in theobesemales.
While both median SHBG and TT concentrations were significantly (p0.001) lower in obese sub-
jects during mid- and late- puberty, median FT, LH, FSH and PSA levels were comparable to those
of controls. In contrast, serum E2 concentrations were significantly (p0.001) higher in the obese
group at all pubertal stages.
Conclusion: Obese boys have lower circulating SHBG and TT, but similar FT concentrations during
mid- and late-puberty in parallel with a normal pubertal progression and serum PSA levels. Our
data indicate that in obese boys, serum FT concentration is a better marker of androgen activity
than TT. On the other hand, skeletal maturation and E2 were increased from the beginning of
puberty, suggesting a significant contribution of hyperestrogenemia in the advancement of skel-
etal maturation in obese boys.
It is well-known that obesity in childhood is associatedwith an accelerated growth and skeletalmaturation (1,
2, 3, 4), but it remains unclear which hormonal changes
aremost important for stimulating the skeletalmaturation
in this particular condition (5, 6, 7). Moreover, only very
limited and contrasting data have beenpublished concern-
ing pubertal development and sex steroids (testosterone
(T) as well as estradiol (E2) concentrations), especially in
male obese adolescents. Whereas some authors found an
advanced sexual maturation in obese boys (8, 9, 10), oth-
ers reported a normal (1, 2) or even a delayed genital de-
velopment (1, 3, 11).
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Furthermore, there is controversy about T concentra-
tions in obese children and adolescents. In prepubertal
obese boys increased total T (TT) concentrations (12, 13),
as well as normal (14) and low TT levels have been de-
scribed (2, 15), whereas in pubertal boys normal (12), as
well as decreased TT concentrations have been reported
(2, 16, 17, 18). Poor assessment of pubertal staging, small
study groups (14, 15), lack of age- matched control group
(2) and the use of direct immunoassays for TT determi-
nation (12, 16, 17) might explain these contrasting hor-
monal findings between studies. Moreover, the well-
known lower SHBG production in obesity, especially
during puberty, might be responsible for the finding of
lower TT concentration in obese adolescents (2, 12, 15,
16). Little experience exits with free T (FT) in adolescent
obesity (16, 18).Therefore, in thepresent studyTT, SHBG
and FT were assessed as markers of androgen secretion
and both clinical (genital development) and biological
(prostatic specific antigen (PSA) concentrations) markers
of androgen activity were assessed in a well described
group of obese adolescents. We hypothesized a normal
genital development in association with normal FT con-
centrations and a more rapid skeletal maturation in rela-
tion to increased E2 levels.
Materials and Methods
Subjects
Ninetymale obese adolescents (BMI SDS2), aged 10–19
years, were investigated at the entry of a residential weight-loss
program at the Zeepreventorium in De Haan, Belgium. Ninety
age-matched healthy normal-weighted controls were randomly
selected from an ongoing longitudinal study evaluating changes
in bone geometry, bone maturation and muscle strength in re-
lation to sex steroids in childhood and adolescence. These
healthy children were recruited by letters distributed in several
schools within the Ghent area. Subjects with a history of hypo-
gonadism, panhypopituitarism, diabetes, previous or ongoing
treatment with T or oral steroids were excluded. Both study
protocols were approved by the Ethical Committee of the Ghent
University Hospital. Informed consent was obtained from the
parents and all participants gave their assent.
Methods
Anthropometry and sexual maturation
Standing height was measured to the nearest 0.1 cm using a
Harpenden stadiometer (Holtain Ltd, Crymuch, UK). Body
weight was measured in light indoor clothing without shoes to
the nearest 0.5 kg. Waist circumference, defined as the smallest
abdominal circumference if present or otherwise measured half-
way between the iliac crest and the rib cage, was determined to
the nearest 0.1 cm. All anthropometric measurements were per-
formed by the same trained physician (SV). The standard devi-
ation score (SDS) for body height, weight, waist circumference
and BMI was computed using the reference data of the 2004
Flemish growth study (19). Pubertal status of the subjects was
assessed by trained pediatricians according to the method estab-
lished by Tanner (Tanner Genital Staging: stage 1: prepuberty;
stage 5: postpuberty). Testicular volume was determined with a
Prader orchidometer in a subgroup of 40 consenting obese boys
and their respective controls.
Bone age determination
Bone age reading of an X- ray of the left hand and wrist was
done by two independent experienced pediatric radiologists,
blinded for the chronological age, using the Greulich and Pyle
method (20). The mean of both readings was taken, but if the
difference was more than one year a third independent reading
(by a trained pediatrician) was performed and the two closest
estimates were retained for final calculations. Skeletal age dif-
ferences (SAD) were calculated by subtracting the chronological
age (CA) from the skeletal age (BA) (SAD  BA –CA): positive
differences reflecting anaccelerated skeletalmaturation andneg-
ative differences a delayed bone maturation.
Hormonal measurements
Venous blood samples in the obese group were obtained be-
tween 0800 and 1000 hours after overnight fasting. Blood sam-
ples in the age-matched control group were collected within the
same time interval, but allowing a small breakfast. All samples
were stored at – 80°C until batch analysis. Commercial auto-
mated immunoassays were used to measure SHBG, LH, FSH,
DHEAS, PSA (Roche Diagnostics, Mannheim, Germany). The
intra- and interassay coefficients of variation (CV’s) for all assays
were less than 10%.The lower detection limit for PSAwas 0.003
ng/ml and the intra-assay and interassay CV’s were respectively
1.2% and 3.5%. Serum E2, TT and androstenedione (A) were
determined by liquid chromatography tandem mass spectrom-
etry (AB Sciex 5500 triple-quadrupole mass spectrometer; AB
173 Sciex, Toronto Canada). Serum limit of quantification
(LOQ) was 0.5 pg/mL (1.9 pmol/L) for E2 and the interassay
CVwas4.0%at21pg/mL (77pmol/L) (21). SerumLOQwas1.2
ng/dl for TT and the interassay CV was 8.3% at 36.7 ng/dl and
3.1% at 307.8 ng/dl. Serum LOQ was 4.25 ng/dl for A and the
interassayCVwas2.9%at 59.8 ng/dl. SerumFTwasdetermined
by equilibrium dialysis (FT dialysis) (22), CV of the method
calculated from duplicate measurements is 11.7%. FT was also
calculated (cFT) in all subjects from the concentrations of TT,
SHBG and albumin according to Vermeulen et al (22). The re-
sults for FTdialysis and cFT are not substantially different as can
be seen froma comparisonbyPassing-Bablok andBland-Altman
analysis (see supplemental data).
Statistics
Normality was checked using QQ-plots and Shapiro-Wilk
tests. The anthropometric data showed at normal distribution,
hormonal datawere however not normally distributed. Data are
presented as mean  standard deviation or as medians (25th –
75th percentile) in case of a non-normal distribution. Compar-
ison between obese and control groups were performed using
parametric independent T-tests or ANOVA, when criteria for
normality were met. In other cases, Mann-Whitney U tests were
used. Between-group differences of categorical variables were
calculated with 2 tests. The difference was considered statisti-
cally significant at P .05. To study hormonal parameters and
anthropometric parameters in the obese boys compared to the
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controls taking pubertal stage into account as presented in figure
1 and figure 2, linear regression analysis was used. Hormonal
parameters TT, FT, E2, LH, SHBG, A, DHEAS and PSA under-
went a Box-Cox transformation to enhance normality (trans-
formation factors were TT:0.49; FT: 0.42; E2: 0.32;
LH:  0.63; SHBG: -0.29; PSA: 0.23, A: 0.40;
DHEAS: 0.26). Box-Cox transformations were performed
using MedCalc for Windows, version 12.5 (MedCalc Software,
Ostend, Belgium). Based on the available literature (13, 18) on
sex steroid (TT, FT) levels determined by LC-MS/MS and SHBG
levels in obese prepubertal and late pubertal boys, sample size
calculations were performed using Medcalc for Windows, ver-
sion 12.4.00 (MedCalc Software, Ostend, Belgium) (: 0.05;
ß:0.20).We calculated a necessary sample size of 7 to 14 children
in each group at the different pubertal stages to discern the pub-
lished differences in TT, FT and SHBG between both groups.
Post hoc power calculations on our E2 analyses using G*power
(version 3.1.5) demonstrated a power between 70 and 99% at
the different pubertal stages. Data were analyzed using SPSS
software version 19.0.
Results
Comparison of anthropometric data and sexual
and skeletal development between obese boys
and age-matched controls
Table 1 summarizes the anthropometric characteristics
and Tanner stages of both groups. Mean body weight
(SDS), BMI (SDS) and waist circumference (SDS) of the
obese group were almost double of
those of normal-weighted peers.
Mean BMI SDS did not differ be-
tween the different pubertal stages in
the control group, while BMI SDS at
Tanner stage G5 was found to be
highest in the obese group (BMI SDS
G4: 2.6  0.25; BMI SDS G5:3.0 
0.35; P  .001 ) (figure 1). More-
over, waist circumference SDS at
Tanner genital stage 5 was signifi-
cantly higher than waist circumfer-
ence SDS at Tanner genital stage 4 in
the obese group (waist circumfer-
ence SDS G4: 2.5  0.28; waist cir-
cumference SDS G5:2.7 0.24; P
.05).Height andheight SDSwerenot
significantly different between both
groups by ANOVA analysis (figure
1,Table 1).Height andheight SDSof
prepubertal and early-pubertal (G1
and G2) obese children were signif-
icantly higher compared to their
healthy peers (height :G1-G2: obese:
158  6 vs. controls: 151  7 cm,
P .001; height SDS:G1-G2: obese:
0.6  1.1 vs. controls:-0.06  1.1, P  .05). Although
skeletal maturation is advanced in obese children from
Tanner stage 1 to 4 (0.001), there is no significant dif-
ference inpubertal developmentbetweenbothgroups (fig-
ure 1, Table 1). Moreover, studying a subgroup of 40
obese adolescents and their matched controls no differ-
ence in testicular volumewas observed (figure 1). Anthro-
pometric characteristics of this subpopulation were sim-
ilar to the whole population (data not shown).
Comparison of hormonal and biological
parameters between obese adolescents and age-
matched controls
Before pubertal onset, TT was similar, while SHBG
concentrations were lower and FT, DHEAS, A and E2
higher in obese boys (Table 2). There was a significant
positive correlation between FT andDHEAS and between
FT and A (spearman rank correlation coefficient (r) r(D-
HEAS-FT)0.79 P .001; r(A-FT) 0.71 P .001). As
shown in figure 2, significantly higher sex steroids (TT, FT
and E2) and PSA concentrations were foundwith advanc-
ing pubertal stage in both groups (P  .001) (figure 2,
Table 2). The subanalysis in the different Tanner genital
stages showed that obese adolescents (at least stage G2)
have lower SHBG levels at every pubertal stage, lower TT
concentrations from stageG3onward, but similar FT con-
Figure 1. Height (a), bone age (b), BMI (c) and testicular volume (d) at different pubertal stages
in obese adolescents compared to their age-matched controls. The line plots present mean
height, BMI, bone age and testicular volume for each pubertal stage (prepuberty: 1; postpuberty:
5) for the two study groups. The error bars represent 1 SEM. The obese group is presented by
the dotted line and the control group (age-matched controls) by the full line. The interconnecting
lines do not present longitudinal data.
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centrations, except for adolescents in pubertal stage 5.
There was no significant difference between values ob-
tained from FT dialysis and cFT (cFT 0.0109 0.9762
FT dialysis). No significant difference in circulating LH,
FSHandPSAconcentrationswas foundbetween theobese
boys and their controls. Serum E2 concentrations and
E2/TT ratio were significantly higher in the obese adoles-
cents (P  .01).
Associations between the degree of obesity and
hormonal parameters in the obese boys
Inorder to study the importanceof thedegreeof obesity
on hormonal parameters, associations between the degree
of obesity, expressed as BMI SDS andwaist circumference
SDS, and TT, FT, SHBG, E2 and PSA were studied using
linear regression (including pubertal stage) in the obese
group only. Waist circumference SDS was a negative pre-
Figure 2. Total testosterone (a), SHBG (b), Free testosterone (c), Estradiol (d), LH (e) and PSA (f) in obese boys and their age-matched controls at
different pubertal stages. The line plots present median TT, SHBG, FT, E2, LH and PSA levels for each pubertal stage (prepuberty: 1; postpuberty: 5)
for the two study groups. Since the hormonal data do not meet the criteria for a normal distribution, data are presented as medians and the error
bars represent 95th confidence interval (CI). The obese group is presented by the dotted line and the control group (age-matched controls) by the
full line. The interconnecting lines do not present longitudinal data.
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dictor of TT (waist circumference SDS: ß - 0.18 P .01)
and FT testosterone (waist circumference SDS :ß - 0.13
P  .05) levels. However, no association between BMI
SDS and TT or FT was found. There was a trend to a
negative association between BMI SDS and waist circum-
ference SDSandSHBG(BMISDS:ß - 0.20P .08;waist
circumference SDS :ß - 0.20 P  .06). BMI SDS was a
positive predictor ofE2 levels (BMISDS: ß0.20P .01).
No association was found between waist circumference
SDS and E2. All results remained unchanged when FT
dialysis was substituted by cFT in the analyses.
Discussion
The present study investigates both androgen secretion
(assessed by serum TT and FT concentrations using sen-
sitive assays) and androgen activity using detailed clinical
and biological assessment of sexual (Tanner genital stag-
ing, PSA) as well as skeletal (bone age readings of the left
hand and wrist ) maturation in a group of obese prepu-
bertal and pubertal boys. Our results demonstrate that
pubertal obese boys have lower TT levels, higher E2 but
normal FT levels, at least during mid- and late puberty
These hormonal differences might be responsible for the
observed dissociation between an advanced skeletal mat-
uration (mean advancement around 1 year) and a normal
sexualmaturation (similar pubertal stage distribution and
PSA concentrations). Our data indicate that FT is a better
indicator of androgen exposure than TT, explaining the
normal pubertal progression and PSA production in male
obese adolescents and suggest that the increased estrogen
production and aromatization might be linked to the ad-
vanced skeletal maturation during pubertal progression.
Firstly, we confirmed the presence of an accelerated
growth and skeletal maturation during childhood and
early stages of puberty in our group of obese children and
adolescents, who had a longstanding and persisting obe-
sity, necessitating a residential weight loss program (1, 2,
3, 4). This accelerated growth and bone maturation con-
trasts with the finding of a normal androgen secretion and
activity during this period, but is in accordance with the
increasing estrogen production and aromatization.














Age (y) 90 14.6  2.2 90 14.5  2.2 ns
Height (cm) 90 169.0  11 90 167  13 ns
Height (SDS) 90 0.36  1.1 90 0.11  1.0 ns
Weight (kg) 90 104.8 
26.0
90 55.6  15.0 0.001
Weight (SDS) 90 2.9  0.6 90 0.03  0.9 0.001
BMI (kg/m2) 90 36.2  5.8 90 19.5  3.2 0.001
BMI (SDS) 90 2.6  0.37 90 0.04  0.97 0.001
Waist circumference
(cm)
85 109  15 85 69  8 0.001
Waist circumference
(SDS)
85 2.5  0.28 85 0.06  0.88 0.001
Skeletal
maturation
Bone age (y) 90 15.6  2.2 90 14.6  2.6 0.01
Difference age-bone
age (y)









G1 8 8.8% 11 12.1% ns (2)
G2 17 18.7% 14 15.4%
G3 13 14.3% 12 13.2%
G4 30 33.0% 31 34.1%
G5 23 25.3% 23 25.3%
Comparison between obese boys and age-matched controls were performed using parametric independent t-tests. Between-group differences of
categorical variables were calculated using -square tests.
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TT (ng/dl) G1 8 6.3 (5.8–10.3) 11 6.2 (4.8–7.3) Ns
G2 16 19.9 (10.1–67.2) 14 20.7 (9.0–44.8) Ns
G3 13 170 (32.6–317) 12 227 (170–293) Ns
G4 30 300 (201–365) 30 423 (326–504) 0.001
G5 23 335 (265–469) 23 517 (445–616) 0.001
FT dialysis (ng/
dl)
G1 8 0.12 (0.1–0.15) 11 0.04 (0.03–0.06) 0.001
G2 16 0.45 (0.24–1.0) 14 0.13 (0.08–0.40) 0.05
G3 13 3.2 (0.5–6.2) 12 2.6 (1.5–4.7) Ns
G4 30 6.7 (5.1–9.3) 30 8.0 (5.9–10.6) Ns
G5 23 8.8 (6.7–10.3) 23 11.6 (9.1–13.3) 0.01
cFT (ng/dl) G1 8 0.13 (0.11–0.16) 11 0.04 (0.03–0.06) 0.001
G2 16 0.44 (0.24–1.1) 14 0.14 (0.07–0.39) 0.05
G3 13 3.1 (0.5–6.5) 12 2.5 (1.4–4.7) Ns
G4 30 6.5 (5.2–8.8) 30 7.8 (5.4–9.9) Ns
G5 23 8.9 (7.1–9.8) 23 11,3 (9.8–12.8) 0.01
SHBG (nmol/
liter)
G1 8 33.6 (28.4–40.4) 11 99.0 (73.0–187) 0.001
G2 16 27.5 (20.2–44.9) 14 115.9 (73.6–148.2) 0.001
G3 13 35.7 (23.7–43.9) 12 79.9 (52.0–93.1) 0.001
G4 30 21.3 (17.2–29.7) 30 36.3 (28.7–44.5) 0.001
G5 23 17.6 (15.4–23.8) 23 33.2 (26.4–38.5) 0.001
E2 (ng/liter) G1 8 1.9 (1.4–3.0) 11 1.0 (0.5–1.0) 0.001
G2 16 3.5 (2.8–5.4) 14 1.0 (0.5–1.4) 0.001
G3 13 10.6 (4.0–16.9) 12 3.5 (2.7–5.3) 0.05
G4 30 18.6 (14.9–25.3) 30 12.4 (8.5–17.0) 0.001
G5 23 34.8 (25.6–41.1) 23 15.7 (13.2–21.0) 0.001
Ratio E2/TT G1 8 0.29 (0.20–0.44) 11 0.14 (0.08–0.19) 0.01
G2 16 0.16 (0.07–0.37) 14 0.04 (0.02–0.1) 0.01
G3 13 0.06 (0.05–0.12) 12 0.02 (0.013–0.021) 0.001
G4 30 0.07 (0.05–0.08) 30 0.03 (0.02–0.04) 0.001
G5 23 0.11 (0.06–0.13) 23 0.03 (0.02–0.05) 0.001
LH (U/liter) G1 8 0.1 (0.1–1.1) 11 0.3 (0.1–0.5) Ns
G2 16 1.6 (0.65–1.8) 14 1.3 (0.53–1.8) Ns
G3 13 2.6 (1.1–3.2) 12 3.1 (2.3–3.5) Ns
G4 30 4.4 (3.4–5.5) 30 3.7 (2.5–4.5) 0.05
G5 23 4.6 (3.8–6.0) 23 3.9 (3.0–5.3) Ns
FSH (U/liter) G1 8 1.8 (1.1–2.8) 11 1.6 (1.1–2.1) Ns
G2 16 2.1 (1.6–3.1) 14 2.1 (1.3–2.3) Ns
G3 13 3.0 (1.8–4.6) 12 2.0 (1.8–2.8) Ns
G4 30 3.7 (2.8–5.1) 30 3.1 (2.1–4.7) Ns
G5 23 2.6 (2.0–4.1) 23 2.7 (1.5–4.7) Ns
DHEAS (g/dl) G1 8 138 (114–152) 11 89.6 (41.1–106) 0.01
G2 16 174 (114–244) 14 133 (81.5–180) Ns
G3 13 225 (144–288) 12 142 (87.1–181) 0.05
G4 30 204 (162–315) 30 221 (157–322) Ns
G5 23 370 (268–469) 23 348 (223–438) Ns
A (ng/dl) G1 8 26.1 (15.7–46.2) 11 17.5 (10.8–20.2) 0.06
G2 16 46.7 (38.7–57.0) 14 23.1 (18.9–34.3) 0.001
G3 13 64.6 (49.6–102) 12 31.1 (25.5–47.5) 0.001
G4 30 79.4 (58.7–93.5) 30 47.1 (35.8–73.0) 0.001
G5 23 81.7 (63.0–117) 23 80.9 (66.3–85.3) Ns
PSA (g/liter) G1 8 undetectable 11 undetectable -
G2 17 0.005 (0–0.01) 14 undetectable -
G3 13 0.05 (0.01–0.17) 12 0.025 (0.01–0.16) Ns
G4 30 0.25 (0.16–0.35) 31 0.28 (0.19–0.44) Ns
G5 23 0.46 (0.33–0.67) 23 0.52 (0.27–0.62) Ns
Non-Gaussian distribution: data presented as median (25th 75 th percentile (P25-P75)). Comparison between obese boys and age-matched
controls were performed using non-parametric Mann-Whitney-U tests.
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Secondly, we found a normal genital development in
obese adolescents. Only few other studies have examined
the pubertal development in obese adolescents (1, 2, 3, 11,
23). Our results of a normal pubertal progression is in
accordance with the findings of Denzer et al (2007), re-
porting a normal genital development in German boys in
comparison with the historical Swiss standard of Largo
and Prader (2). Laron et al (2004) also reported in a short
communication no difference in pubertal timing among
136 obese boys and 48 nonobese boys (23). On the other
hand, an increased prevalence of delayed pubertal devel-
opment in obese males has been observed by some pedi-
atric obesity clinics (1, 24). The reasons for this phenom-
enon, is not known, although some recruitment biasmight
be involved, given the well-known accelerated body fat
accumulation in boys occurring before pubertal onset,
promoting some overrepresentation of obese boys with a
delayed sexual maturation in obesity clinics.
Thirdly,we found normal serumPSA concentrations in
obese adolescents. During male development, PSA con-
centrations correlate with the rise in T levels, being high
during mini-puberty, declining to undetectable values by
six months, reappearing by about age 10 years and in-
creasing in concentration thereafter until adulthood (25).
Serum PSA concentration have been found to correlate
with T concentrations during puberty, especially when T
concentrations were adjusted for SHBG levels (26, 27).
This study is the first report of PSAconcentrations inobese
boys and suggests that PSA seems to be a bettermarker for
evaluating androgen activity at tissue level than skeletal
maturation, given it is less influenced by estrogens during
pubertal development
Our study design allowed us to assess the difference in
circulating sex steroids between obese and nonobese ad-
olescents at different pubertal stages. We found clearly
lowerTT inobese adolescents fromstage3onwards.Most
studies have reported low TT levels in obese subjects dur-
ing pubertal progression (2, 16, 17, 18), although two
studies did find normal TT concentrations at Tanner stage
G2 (12, 14). As previously described byDenzer et al 2007,
we found markedly lower SHBG levels at every pubertal
stage possibly caused by the increased insulin levels (28).
Since approximately half of TT is bound to SHBG, it is
likely that the lower SHBG concentrations in obese ado-
lescents can account at least in part for these lower TT
concentrations.Moreover, FT concentrations -as assessed
by the equilibriumdialysismethod-were comparablewith
the concentrations in nonobese subjects at mid- and late
-puberty (G3 and G4). The findings of a normal pubertal
development and normal PSA values indicate that FT lev-
els seem to be a more representative index of androgen
activity during adolescence than TT levels in obese puber-
tal boys. Our finding of higher FT concentrations in pre-
pubertal and early-pubertal obese boys is probably related
to an increased adrenal activity (2, 13) in obese children
and adolescents which seem to be supported by the in-
creasedDHEAS andA levels in our prepubertal and early-
pubertal obese boys and the strong positive correlation
between DHEAS and FT and between A and FT. Taneli et
al(2010) reported lower FT in obese boys at Tanner stage
2, but not at Tanner stage 4 (16). However, in the latter
study FT concentrations were measured by direct radio-
immunoassay (RIA), an inaccurate method that underes-
timates FT concentrations by manifold and is dependent
upon SHBG concentrations (29, 30). In accordance with
Mogri et al(2013), also using a equilibrium dialysis
method,we found that postpubertal obesemales (G5) had
significantly lower FT concentrations compared to their
lean counterparts (18). In adult men FT concentrations
have been reported to be preserved in moderately obese
men and decreased in severely obese subjects due to a de-
ficient gonadotropin secretion, as evidenced by a de-
creased amplitude of secretory LH pulses (31, 32). The
lowerFTconcentrations at completionof puberty inobese
boysmight be related to increasing body fat accumulation
since a higher degree of obesity (assessed as waist circum-
ference SDS) was negatively associated with FT levels in
theobese group.Although theobese adolescentswithaG5
status studied by us had indeed the most severe degree of
obesity, -as shownby their higherBMISDSandwaist SDS,
andhighest E2 concentrations, known toplay amajor role
in negative feedback regulation of LH (33, 34), their
E2/TTwas not higher in comparisonwith earlier pubertal
stages and a single point LHmeasurement was not differ-
ent from lean controls.
The few studies reporting on estrogens in obese boys,
did not find a significant difference in E2 levels between
obese boys and lean controls, but these studies were ham-
pered by a very small sample size (14, 16, 18, 35) as well
as the use of inaccurate immunoassays (14, 16, 35).
The strength of the present study is the comprehensive
and reliable evaluation of pubertal development (by
trained pediatricians), skeletal maturation (by two expe-
rienced radiologists) and sex steroids (measured by highly
sensitive and accurate mass spectrometry-based method-
ology as required when studying low androgen and estro-
gen serum levels in children and adolescents) in an large
group of obese adolescents. Since there are no universally
accepted reference ranges forTTandFT concentrations in
pubertal boys, we used age-matched controls, recruited in
Conversion factor to SI-units for TT from ng/dl to nmol/liter is 0.0347, for FT from ng/dl to nmol/liter is 0.0347, for E2 from ng/liter to pmol/liter is
3.671, for DHEAS from g/dl to nmol/liter is 2.714 , for A from ng/dl to nmol/liter is 0.0349.
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parallel with the obese study subjects to avoid secular
trends. As far as we know this is the first study to present
sex steroid data at different pubertal stages with an ac-
ceptable sample size in obese boys using state-of-the-art
techniques and to have evaluated PSA levels as a marker
for androgen responsiveness in an obese pediatric popu-
lation in relation to FT, measured by equilibrium dialysis.
Given the wide usage of free testosterone calculations, the
cFTwas also included in the analyses. All results remained
unchanged when FT by dialysis was substituted by cFT in
our analyses.
Our study has some limitations. Firstly, our sample size
in the prepubertal and early pubertal group is rather small
especially in comparison with our late-and postpubertal
group. However, after sample size calculations based on
the available literature we are confident that this is not a
major drawback. Secondly, our study is limited by the fact
thatweonly have assessed cross-sectional data. In order to
confirm the underlying mechanisms in the dissociation
between skeletal and sexual maturation, prospective lon-
gitudinal studies are required, ideally with a follow-up
from early childhood at onset of obesity until adulthood.
In conclusion, obese male mid- and late-pubertal ado-
lescents have lower TT concentration, but similar FT lev-
els compared to age-matched lean controls. This normal
androgen activity is reflected in a normal sexual develop-
ment and similar PSA levels. On the other hand, skeletal
maturation and E2 were increased from the onset of pu-
berty, suggesting a significant contribution of hyperestro-
genemia in the advancement of skeletal maturation in
obese boys.
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